Effect of Saliva miltiorrhiza Bunge on antimicrobial activity and resistant gene regulation against Methicillin-Resistant Staphylococcus aureus (MRSA)

Journal of Microbiology

Volumn 45, Issue 4, 2007, Pages 350-357

  Lee, Ji Won ^a   Ji, Young Ju ^a   Lee, Syng Ook ^a   Lee, In Seon ^a  

^a Keimyung University   (South Korea)

Author keywords

Antimicrobial activity; MRSA; Resistant gene; Salvia miltiorrhiza Bunge

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CHLOROFORM; HEXANE; PLANT EXTRACT;

ARTICLE; BACTERIAL GENE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CHLOROFORM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; HEXANES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; SALVIA MILTIORRHIZA; STAPHYLOCOCCUS AUREUS;

EID: 34548402684     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Adams, J.D., M. Wall, and C. Garcia. 2005. Salvia columbariae contains tanshinones. Evidence Based Complement. Altern. Med. 2, 107-110.
2. Bailie, G. and D. Neal. 1988. Vancomycin ototoxicity and netphrotoxity. Med. Toxicol. 3, 376.
3. Battaglia, A., G. Bruni, A. Ardia, and G. Sachetti. 1989. On behalf of the Italian Nicergoline study group. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study. J. Am. Geriatr. Soc. 37, 295-302.
4. Berger-Bachi, B., L. Barberis-Maino, A. Strassle, and F.H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistant in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219, 263-269.
5. Berger-Bachi, B., A. Strassle, J.E. Gustafson, and F.H. Kayser. 1992. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 36, 1367-1373.
6. Bertrand, G., M.E. Jose, and M. Philippe. 2005. β-Lactams against methicillin-resistant Staphylococcus aureus. Cur. Opin. Pharmacol. 5, 479-489.
7. Bramley, A.J., A.H. Patel, M. O'Reilly, R. Foster, and T.J. Foster. 1989. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect. Immun. 57, 2489-2494.
8. Cao, E.H., X.Q. Liu, J.J. Wang, and N.F. Xu. 1996. Effect of natural antioxidant tanshinone IIA on DNA damage by lipid peroxidation in liver cells. Free Rad. Biol. Med. 20, 801-806.
9. Chang, H.M., K.P. Cheng, T.F. Chaong, H.F. Chow, K.Y. Chui, P.M. Hon, F.W. Tan, Y. Yang, Z.P. Zhong, C.M. Lee, H.L. Sham, C.F. Chan, Y.X. Cui, and H.N. Wong. 1990. Structure elucidation and total synthesis of new tanshinones isolated from Salvia miltiorrhiza Bunge (Danshen). J. Org. Chem. 55, 3537-3543.
10. Chang, H.M., K.Y. Chui, F.W.L. Tan, Y. Yang, Z.P. Zhong, C.M. Lee, H.L. Sham, and H.N. Wong. 1991. Structure activity relationship of miltirone, an active central benzodiazepine receptor ligand isolated from Salvia miltiorrhiza Bunge (danshen). J. Med. Chem. 34, 1675-1692.
11. Chen, Y.H., S.J. Lin, H.H. Ku, M.S. Shiao, F.Y. Lin, J.W. Chen, and Y.L. Chen. 2001a. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J. Cell Biochem. 82, 512-521.
12. Chen, Y.L., S.P. Yang, M.S. Shiao, J.W. Chen, and S.J. Lin. 2001b. Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits. J. Cell Biochem. 83, 484-493.
13. Dutton, E.K., S.A. Ottum, T.C. Bolken, C.A. Franke, and D.E Hruby. 2000. Expression of active monomeric and dimeric nuclease A from the Gram-positive Streptococcus gordonii surface protein expression system. Protein Expr. Purif. 19, 158-172.
14. Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9, 486-493.
15. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F.C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-136.
16. Hung, H.H., Y.L. Chen, S.J. Lin, S.P. Yang, C.C. Shih, M.S. Shiao, and C.H. Chang. 2001. A salvianolic acid B-rich fraction of Salvia miltiorrhiza induces neointimal cell apoptosis in rabbit angioplasty model. Histol. Histopathol. 16, 175-183.
17. Iinuma, M., H. Tsuchiya, M. Sato, J. Yokoyama, M. Ohyama, Y. Ohkawa, T. Tanaka, S. Fujiwara, and T. Fuji. 1994. Flavonones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol. 46, 892-895.
18. Ji, X.Y., B.K.H. Tan, and Y.Z. Zhu. 2000. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21, 1089-1094.
19. Ji, X.Y., B.K.H. Tan, Y.C. Zhu, W. Linz, and Y.Z. Zhu. 2003. Comparison of cardio-protective effects using ramipril and danshen for the treatment of acute myocardial infarction in rats. Life Sci. 73, 1413-1426.
20. Kang, B.Y., S.W. Chung, S.H. Kim, S.Y. Ryu, and T.S. Kim. 2000. Inhibition of interleukin-12 and interferon gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacol. 49, 355-361.
21. Kim, S.Y., T.C. Moon, H.W. Chang, K.H. Son, S.S. Kang, and H.P. Kim. 2002. Effects of tanshinone I isolated from Salvia miltiorrhiza Bunge on arachidonic acid metabolism and in vivo inflammatory response. Phytother. Res. 16, 616-620.
22. Lam, B.Y., A.C. Lo, X. Sun, H.W. Luo, S.K. Chung, and N.J. Sucher. 2003. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomed. 10, 286-291.
23. Lay, I.S., J.H. Chiu, M.S. Shiao, W.Y. Lui, and C.W. Wu. 2003. Crude extract of Salvia miltiorrhiza and savianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta. Med. 69, 26-32.
24. Li, H.Y., Y. Li, C.H. Yan, L.N. Li, and X.G. Chen. 2002. Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A. J. Asian Nat. Prod. Res. 4, 271-280.
25. Li, L.N. 1997. Water soluble active components of Salvia miltiorrhiza and related plants. J. Chin. Pharm. Sci. 6, 57-64.
26. Li, X.H. and R.Y. Tang. 1991. Relationship between inhibitory action of tanshinone on neutrophil function and its prophylactic effects on myocardial infarction (Chinese). Zhongguo. Yaoli. Xuebao. 12, 269-272.
27. Liu, J., H.M. Shen, and C.N. Ong. 2001. Role of intracellular thiol depletion, mitochondrial function and reactive oxygen species in Salvia miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. Life Sci. 69, 1833-1850.
28. Myscofski, D.M., E.K. Dutton, E. Cantor, A. Zhang, and D.E. Hruby. 2001. Cleavage and purification of intein fusion proteins using Streptococcus gordonii spex system. Prep. Biochem. Biotechnol. 31, 275-290.
29. National Committee for Clinical Laboratory Standards. 1999. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS Document M7-A2. Villanova, Pensylvania, USA.
30. Nostro, A., G. Bisignano, M. Angela Cannatelli, G. Crisafi, M. Paola Maria, and V. Alonzo. 2001. Effects of Helichrysum italicum extract on growth and enzymatic activity of Staphylococcus aureus. Int. J. Antimicrob. Agents 17, 517-520.
31. Park, C.G., K.H. Bang, S.E. Lee, M.S. Cha, J.S. Seong, S.U. Park, and N.S. Seong. 2001. Antimicrobial effect of various medicinal herb on Staphylococcus aureus. Korean J. Medicinal Crop. Sci. 9, 251-258.
32. Renet, C., G.H. Du, and J.T. Zhang. 2002. Inhibitory effect of the water-soluble extract of Salvia miltiorrhiza on neutrophil-endothelial adhesion. Jpn. J. Pharmacol. 90, 276-280.
33. Ryu, S.Y., Z. No, S.H. Kim, and J.W. Ahn. 1997. Two novel abietane diterpenes from Salvia miltiorrhiza. Planta Med. 63, 44-46.
34. Sabath, L.D. 1982. Mechanisms of resistant to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann. Intern. Med. 97, 339-344.
35. Saletu, B., E. Paulus, and L. Lizmayer, 1995. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia or double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology 117, 385-395.
36. Sato, M., T. Sato, Y. Ose, H. Nagase, H. Kito, and Y. Sakai. 1992. Modulating effect of tanshinones on mutagenic activity of Trp-P-1 and benzo[a]pyrene in Salmonella typhimurium. Mutat. Res. 265, 149-154.
37. Sato, M., H. Tsuchiya, I. Takase, H. Kureshiro, S. Tanigaki, and M. Iinuma. 1995. Antibacterial activity of flavonone isolated from Sophora exigua against methicillin-resistant Staphylococcus aureus and its combination with antibiotics. Phytother. Res. 9, 509-512.
38. Schouten, M.A., J.A.A. Hoogkamp-Korstanje, J.F.G. Meis, and A. Voss. 2000. The European VRE study group prevalence of vancomycin-resistant enterococci in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 19, 816-822.
39. Sun, J., S.H. Huang., B.K. Tan, M. Whiteman, Y.C. Zhu, Y.J. Wu, Y. NG, W. Duan, and Y.Z. Zhu. 2005. Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. Life Sci. 76, 2849-2860.
40. Tang, W. and G. Eisenbrand. 1992. Chinese drug of plant origin: chemistry, pharmacology, and use in traditional and modern medicine, p. 891-902. Springer-Verlag, Berlin, Germany.
41. Yu, S., P. Kuang, T. Kanazawa, K. Onodera, H. Metoki, and Y. Oike. 1998. The effects of radix Salvia miltiorrhizae on lipid accumulation of peroxidized low density lipoprotein in mouse peritoneal macrophages-lipid analysis and morphological studies. J. Tradit. Chin. Med. 18, 292-299.
42. Wang, J.M., H.B. He, Y.Q. Zhu, D.W. Shi, Y.M. Li, and Y. Zhang. 1991. Reversed phase HPLC determination of danshensu and protocatechuic aldehyde in Salvia miltiorrhiza. Acta. Acad. Med. Shanghai 18, 27-32.
43. Wang, N., H.W. Luo, M. Niwa, and J. Ji. 1989. A new platelet aggregation inhibitor from Salvia miltiorrhiza. Planta Med. 55, 390-391.
44. Wang, A.M., S.H. Sha, W. Lesniak, and J. Schacht. 2003. Tanshinone (Salvia miltiorrhizae extract) preparations attenuate aminoglycoside induced free radical formation in vitro and ototoxicity in vivo. Antimicrob. Agents Chemother. 47, 1836-1841.
45. World Health Organization (WHO); the promotion and development of traditional medicine. 1978. Technical report series, p. 279.
46. Wu, B., M. Liu, and S. Zhang. 2005. Danshen for acute ischaemic stroke (Review). Cochrane Library 4, 1-12.
47. Wu, Y.J., C.Y. Hong, S.J. Lin, P. Wu, and M.S. Shiao. 1998. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol. 18, 481-486.
48. Zhang, H.Z., C.J. Hackbarth, K.M. Chansky, and H.F. Chambers. 2001. A proteolytic transmembrane signaling pathway and resistance to β-lactams in staphylococci. Science 291, 1962-1965.
49. Zhou, G., W. Jiang, Y. Zhao, G. Ma, W. Xin, J. Yin, and B. Zhao. 2003. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochem. Pharmacol. 65, 51-57.